| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.12B | 9.57B | 10.20B | 6.61B | 6.05B | 6.00B |
| Gross Profit | 1.55B | 2.36B | 3.46B | 1.89B | 2.16B | 1.88B |
| EBITDA | 1.31B | 586.18M | 2.23B | 1.21B | 1.47B | 1.48B |
| Net Income | -1.31B | -1.00B | 226.10M | 172.19M | 1.51B | 543.19M |
Balance Sheet | ||||||
| Total Assets | 41.06B | 42.54B | 47.26B | 53.42B | 54.80B | 49.90B |
| Cash, Cash Equivalents and Short-Term Investments | 3.45B | 3.18B | 3.92B | 6.62B | 9.58B | 7.81B |
| Total Debt | 27.50B | 25.69B | 28.13B | 35.56B | 34.71B | 31.19B |
| Total Liabilities | 31.19B | 29.44B | 32.39B | 40.68B | 39.80B | 35.73B |
| Stockholders Equity | 9.57B | 12.79B | 14.58B | 12.36B | 14.63B | 13.80B |
Cash Flow | ||||||
| Free Cash Flow | 2.71B | 3.77B | 2.16B | -3.09B | -2.42B | 519.20M |
| Operating Cash Flow | 3.45B | 4.91B | 3.58B | -2.20B | -1.36B | 1.45B |
| Investing Cash Flow | -266.11M | -790.70M | -1.11B | -1.30B | -68.08M | -2.43B |
| Financing Cash Flow | -3.69B | -4.62B | -4.04B | 1.10B | 3.95B | 2.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
54 Neutral | HK$2.45B | -0.73 | -14.14% | 15.28% | -9.95% | -77.31% | |
41 Neutral | HK$1.21B | -0.06 | -158.53% | ― | -19.81% | 19.55% | |
| ― | HK$2.54B | -10.44 | -3.20% | 12.10% | -17.67% | 29.58% | |
51 Neutral | HK$1.77B | 140.16 | 0.11% | 6.35% | 54.72% | 59.72% | |
51 Neutral | HK$2.98B | -1.46 | -10.34% | 4.12% | -4.95% | -29.73% | |
49 Neutral | HK$2.47B | 19.21 | 0.82% | 6.86% | -31.03% | -31.43% |